Walden Group Navigation
  • About Us
    • Overview
    • Corporate Sales & Divestures
    • Acquisition Searches
    • Strategic Consulting
  • Completed Transactions
  • Sectors Covered
  • Testimonials
  • Key People
  • Blog
  • Contact Us
  • About Us
    • Overview
    • Corporate Sales & Divestures
    • Acquisition Searches
    • Strategic Consulting
  • Completed Transactions
  • Sectors Covered
  • Testimonials
  • Key People
  • Blog
  • Contact Us
Home Blog The Walden Group 2024 Medical Device Outsourcing Report
Strategic Healthcare Mergers and Acquisitions (M&A)
  • (914) 332-9700
  • Email Us
Strategic Health M&A Report
  • About Us
    • Overview
    • Corporate Sales & Divestures
    • Acquisition Searches
    • Strategic Consulting
  • Completed Transactions
  • Sectors Covered
  • Testimonials
  • Key People
  • Blog
  • Contact Us

The Walden Group 2024 Medical Device Outsourcing Report

1/24/2024

The Walden Group is pleased to provide access to its 2024 Medical Device Outsourcing Developments report, which includes:

  •      Highlights from the 2024 JPM Healthcare Conference
  •      Key Outsourcing Trends
  •      Developments in Surgical Robotics, AI, 3D Printing and more.
  •      Notable CDMO and OEM Transactions
  •      And More

Click Here to download the Report.


Back To Blog

Search By Keyword

Recent blog posts

  • The Walden Group Releases 2024 Year-End Strategic Healthcare M&A Report
  • The Walden Group Represented RICA Surgical in its Sale to Mastel Surgical, a Pacific Surgical Company
  • The Walden Group Releases Q2 2024 Strategic Healthcare M&A Report
  • The Walden Group Releases Q1 2024 Strategic Healthcare M&A Report
  • The Walden Group Releases 2023 Year-End Strategic Healthcare M&A Report
  • The Walden Group 2024 Medical Device Outsourcing Report
  • The Walden Group Releases Q3 2023 Strategic Healthcare M&A Report
  • The Walden Group Releases Q2 2023 Strategic Healthcare M&A Report
  • The Walden Group Releases Q1 2023 Strategic Healthcare M&A Report
  • Werfen Group Buys Immucor for $2b
  • The Walden Group Releases 2022 Year-End Strategic Healthcare M&A Report
  • Shockwave Medical to Acquire Neovasc for $100m
  • Zimmer Biomet Acquires Embody for $150m
  • The Walden Group Represented Total Titanium, Inc in Its Sale to a Subsidiary of Bausch + Lomb Corporation
  • The Walden Group Releases Q3 2022 Strategic Healthcare M&A Report

The Walden Group | (914) 332-9700 | office@waldenmed.com

Tarrytown Corporate Center, 560 White Plains Rd.

Tarrytown, New York 10591

  • About Us
  • Completed Transactions
  • Sectors Covered
  • Testimonials
  • Key People
  • Blog
  • Contact Us

©2025 The Walden Group | All Rights Reserved

Toggle the Widgetbar